Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback